CTI BIOPHARMA - Trademark Details
Status: 702 - Section 8 & 15-Accepted And Acknowledged
Image for trademark with serial number 86978798
Serial Number
86978798
Registration Number
4980005
Word Mark
CTI BIOPHARMA
Status
702 - Section 8 & 15-Accepted And Acknowledged
Status Date
2021-09-30
Filing Date
2014-08-06
Registration Number
4980005
Registration Date
2016-06-14
Mark Drawing
3000 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s) Typeset
Design Searches
020133, 040703, 260121, 261709 - Grotesque men formed by letters, numbers, punctuation or geometric shapes. Geometric figures or combinations of geometric figures representing a person. Circles that are totally or partially shaded. Curved line(s), band(s) or bar(s).
Published for Opposition Date
2015-12-01
Attorney Name
Law Office Assigned Location Code
L70
Employee Name
LEE, YAT SYE I
Statements
Indication of Colors claimed
Color is not claimed as a feature of the mark.
Disclaimer with Predetermined Text
"BIOPHARMA"
Description of Mark
The mark consists of a stylized image of a stick figure design to the left hand side of the wording "CTI BIOPHARMA".
Goods and Services
Research, development, engineering, testing, product evaluation, and inspection in the field of pharmaceutical preparations and products; pharmaceutical research and development; providing technical consultation in the field of pharmaceutical product research and development; medical and scientific research, namely, conducting clinical trials for others for pharmaceutical preparations used for the treatment of cancer, immunological, inflammatory and infectious diseases, and pain; scientific research, consulting, and advice in the fields of biotechnology, pharmaceutical research and development, and the life sciences; pharmaceutical, medical and laboratory research services in the fields of pharmaceuticals, cancer, genetic disorders, and the life sciences; providing medical testing services for research purposes and medical and scientific research information in the fields of pharmaceuticals, the life sciences, clinical trials, medicine, oncology, hematology, cancer, disease classification, and genetic disorders; and consultation related to the foregoing
Classification Information
International Class
042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services. - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software; legal services.
US Class Codes
100, 101
Class Status Code
6 - Active
Class Status Date
2014-08-15
Primary Code
042
First Use Anywhere Date
2014-05-31
First Use In Commerce Date
2014-05-31
Current Trademark Owners
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Frances M. Jagla
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship TypeReel Number
Prior Registration2854845
Continuity Parent86359462
Trademark Events
Event DateEvent Description
2014-08-09NEW APPLICATION ENTERED IN TRAM
2014-08-15NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
2014-08-16NOTICE OF DESIGN SEARCH CODE E-MAILED
2014-08-31ASSIGNED TO EXAMINER
2014-08-31NON-FINAL ACTION WRITTEN
2014-08-31NON-FINAL ACTION E-MAILED
2014-08-31NOTIFICATION OF NON-FINAL ACTION E-MAILED
2015-02-25TEAS RESPONSE TO OFFICE ACTION RECEIVED
2015-03-05ASSIGNED TO LIE
2015-03-12CORRESPONDENCE RECEIVED IN LAW OFFICE
2015-03-12TEAS/EMAIL CORRESPONDENCE ENTERED
2015-04-29FINAL REFUSAL WRITTEN
2015-04-29FINAL REFUSAL E-MAILED
2015-04-29NOTIFICATION OF FINAL REFUSAL EMAILED
2015-10-19TEAS REQUEST FOR RECONSIDERATION RECEIVED
2015-10-19CORRESPONDENCE RECEIVED IN LAW OFFICE
2015-10-20TEAS/EMAIL CORRESPONDENCE ENTERED
2015-10-26APPROVED FOR PUB - PRINCIPAL REGISTER
2015-10-29LAW OFFICE PUBLICATION REVIEW COMPLETED
2015-11-11NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
2015-12-01PUBLISHED FOR OPPOSITION
2015-12-01OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
2016-01-26NOA E-MAILED - SOU REQUIRED FROM APPLICANT
2016-02-23TEAS REQUEST TO DIVIDE RECEIVED
2016-02-23TEAS STATEMENT OF USE RECEIVED
2016-04-12CASE ASSIGNED TO INTENT TO USE PARALEGAL
2016-02-23DIVISIONAL REQUEST RECEIVED
2016-04-14DIVISIONAL PROCESSING COMPLETE
2016-02-23USE AMENDMENT FILED
2016-04-14STATEMENT OF USE PROCESSING COMPLETE
2016-04-15NOTICE OF DESIGN SEARCH CODE E-MAILED
2016-05-07ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
2016-05-06TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2016-05-06ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2016-05-10NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
2016-06-14REGISTERED-PRINCIPAL REGISTER
2020-05-06TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-05-06TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-05-06ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-05-06TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
2020-05-06TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-05-06APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-05-14TEAS CHANGE OF OWNER ADDRESS RECEIVED
2020-05-14TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
2020-05-14ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
2020-05-14TEAS CHANGE OF CORRESPONDENCE RECEIVED
2020-05-14APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
2020-06-15REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
2021-06-14COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
2021-06-16TEAS SECTION 8 & 15 RECEIVED
2021-09-30CASE ASSIGNED TO POST REGISTRATION PARALEGAL
2021-09-30REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
2021-09-30NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED